4D Molecular Therapeutics... (FDMT)
3.31
-0.03 (-0.90%)
At close: Apr 28, 2025, 11:24 AM
4D Molecular Therapeutics Revenue
4D Molecular Therapeutics reported an annual revenue of $37K, reflecting a -99.82% growth. For the quarter ending December 31, 2024, 4D Molecular Therapeutics generated $1K in revenue.
Revenue (ttm)
$37K
Revenue Growth
-99.82%
Price / Sales Ratio
8120.72
Revenue / Employee
$163
Employees
227
Market Cap
153.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 37K | -99.82% |
| Dec 31, 2023 | 20.72M | +562.29% |
| Dec 31, 2022 | 3.13M | -82.65% |
| Dec 31, 2021 | 18.04M | +32.52% |
| Dec 31, 2020 | 13.61M | n/a |